1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Dry Age-Related Macular Degeneration Market Size 2016-2026
  • 2.1.2 Dry Age-Related Macular Degeneration Market Size CAGR by Region 2020 VS 2021 VS 2026
• 2.2 Dry Age-Related Macular Degeneration Segment by Type
  • 2.2.1 Oral
  • 2.2.2 Oral
• 2.3 Dry Age-Related Macular Degeneration Market Size by Type
  • 2.3.1 Global Dry Age-Related Macular Degeneration Market Size CAGR by Type
  • 2.3.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2016-2021)
• 2.4 Dry Age-Related Macular Degeneration Segment by Application
  • 2.4.1 Above 40 Years
  • 2.4.2 Above 60 Years
  • 2.4.3 Above 75 Years
• 2.5 Dry Age-Related Macular Degeneration Market Size by Application
  • 2.5.1 Global Dry Age-Related Macular Degeneration Market Size CAGR by Application
  • 2.5.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Application (2016-2021)

3 Dry Age-Related Macular Degeneration Market Size by Players

• 3.1 Dry Age-Related Macular Degeneration Market Size Market Share by Players
  • 3.1.1 Global Dry Age-Related Macular Degeneration Revenue by Players (2019-2021E)
  • 3.1.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Players (2019-2021E)
• 3.2 Global Dry Age-Related Macular Degeneration Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Dry Age-Related Macular Degeneration by Regions

• 4.1 Dry Age-Related Macular Degeneration Market Size by Regions (2016-2021)
• 4.2 Americas Dry Age-Related Macular Degeneration Market Size Growth (2016-2021)
• 4.3 APAC Dry Age-Related Macular Degeneration Market Size Growth (2016-2021)
• 4.4 Europe Dry Age-Related Macular Degeneration Market Size Growth (2016-2021)
• 4.5 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth (2016-2021)

5 Americas

• 5.1 Americas Dry Age-Related Macular Degeneration Market Size by Country (2016-2021)
• 5.2 Americas Dry Age-Related Macular Degeneration Market Size by Type (2016-2021)
• 5.3 Americas Dry Age-Related Macular Degeneration Market Size by Application (2016-2021)
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Dry Age-Related Macular Degeneration Market Size by Region (2016-2021)
• 6.2 APAC Dry Age-Related Macular Degeneration Market Size by Type (2016-2021)
• 6.3 APAC Dry Age-Related Macular Degeneration Market Size by Application (2016-2021)
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia

7 Europe

• 7.1 Europe Dry Age-Related Macular Degeneration by Country (2016-2021)
• 7.2 Europe Dry Age-Related Macular Degeneration Market Size by Type (2016-2021)
• 7.3 Europe Dry Age-Related Macular Degeneration Market Size by Application (2016-2021)
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Dry Age-Related Macular Degeneration by Region (2016-2021)
• 8.2 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Type (2016-2021)
• 8.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Application (2016-2021)
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Dry Age-Related Macular Degeneration Market Forecast

• 10.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2021-2026)
  • 10.1.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2021-2026)
  • 10.1.2 Americas Dry Age-Related Macular Degeneration Forecast
  • 10.1.3 APAC Dry Age-Related Macular Degeneration Forecast
  • 10.1.4 Europe Dry Age-Related Macular Degeneration Forecast
  • 10.1.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast
• 10.2 Americas Dry Age-Related Macular Degeneration Forecast by Countries (2021-2026)
  • 10.2.1 United States Dry Age-Related Macular Degeneration Market Forecast
  • 10.2.2 Canada Dry Age-Related Macular Degeneration Market Forecast
  • 10.2.3 Mexico Dry Age-Related Macular Degeneration Market Forecast
  • 10.2.4 Brazil Dry Age-Related Macular Degeneration Market Forecast
• 10.3 APAC Dry Age-Related Macular Degeneration Forecast by Region (2021-2026)
  • 10.3.1 China Dry Age-Related Macular Degeneration Market Forecast
  • 10.3.2 Japan Dry Age-Related Macular Degeneration Market Forecast
  • 10.3.3 Korea Dry Age-Related Macular Degeneration Market Forecast
  • 10.3.4 Southeast Asia Dry Age-Related Macular Degeneration Market Forecast
  • 10.3.5 India Dry Age-Related Macular Degeneration Market Forecast
  • 10.3.6 Australia Dry Age-Related Macular Degeneration Market Forecast
• 10.4 Europe Dry Age-Related Macular Degeneration Forecast by Country (2021-2026)
  • 10.4.1 Germany Dry Age-Related Macular Degeneration Market Forecast
  • 10.4.2 France Dry Age-Related Macular Degeneration Market Forecast
  • 10.4.3 UK Dry Age-Related Macular Degeneration Market Forecast
  • 10.4.4 Italy Dry Age-Related Macular Degeneration Market Forecast
  • 10.4.5 Russia Dry Age-Related Macular Degeneration Market Forecast
• 10.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast by Region (2021-2026)
  • 10.5.1 Egypt Dry Age-Related Macular Degeneration Market Forecast
  • 10.5.2 South Africa Dry Age-Related Macular Degeneration Market Forecast
  • 10.5.3 Israel Dry Age-Related Macular Degeneration Market Forecast
  • 10.5.4 Turkey Dry Age-Related Macular Degeneration Market Forecast
  • 10.5.5 GCC Countries Dry Age-Related Macular Degeneration Market Forecast
• 10.6 Global Dry Age-Related Macular Degeneration Forecast by Type (2021-2026)
• 10.7 Global Dry Age-Related Macular Degeneration Forecast by Application (2021-2026)

11 Key Players Analysis

• 11.1 Santen Pharmaceuticals
  • 11.1.1 Santen Pharmaceuticals Company Information
  • 11.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
  • 11.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.1.4 Santen Pharmaceuticals Main Business Overview
  • 11.1.5 Santen Pharmaceuticals Latest Developments
• 11.2 Allergan
  • 11.2.1 Allergan Company Information
  • 11.2.2 Allergan Dry Age-Related Macular Degeneration Product Offered
  • 11.2.3 Allergan Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.2.4 Allergan Main Business Overview
  • 11.2.5 Allergan Latest Developments
• 11.3 Bausch Health
  • 11.3.1 Bausch Health Company Information
  • 11.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Offered
  • 11.3.3 Bausch Health Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.3.4 Bausch Health Main Business Overview
  • 11.3.5 Bausch Health Latest Developments
• 11.4 Alimera Science
  • 11.4.1 Alimera Science Company Information
  • 11.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Offered
  • 11.4.3 Alimera Science Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.4.4 Alimera Science Main Business Overview
  • 11.4.5 Alimera Science Latest Developments
• 11.5 Phio Pharmaceuticals
  • 11.5.1 Phio Pharmaceuticals Company Information
  • 11.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
  • 11.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.5.4 Phio Pharmaceuticals Main Business Overview
  • 11.5.5 Phio Pharmaceuticals Latest Developments
• 11.6 Ocumension Therapeutics
  • 11.6.1 Ocumension Therapeutics Company Information
  • 11.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Offered
  • 11.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.6.4 Ocumension Therapeutics Main Business Overview
  • 11.6.5 Ocumension Therapeutics Latest Developments
• 11.7 Belite Bio
  • 11.7.1 Belite Bio Company Information
  • 11.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Offered
  • 11.7.3 Belite Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.7.4 Belite Bio Main Business Overview
  • 11.7.5 Belite Bio Latest Developments
• 11.8 Kubota Vision
  • 11.8.1 Kubota Vision Company Information
  • 11.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Offered
  • 11.8.3 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.8.4 Kubota Vision Main Business Overview
  • 11.8.5 Kubota Vision Latest Developments
• 11.9 Particleboard Bio
  • 11.9.1 Iveric Bio Company Information
  • 11.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Offered
  • 11.9.3 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.9.4 Iveric Bio Main Business Overview
  • 11.9.5 Iveric Bio Latest Developments
• 11.10 Eyestem Research
  • 11.10.1 Eyestem Research Company Information
  • 11.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Offered
  • 11.10.3 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.10.4 Eyestem Research Main Business Overview
  • 11.10.5 Eyestem Research Latest Developments

11. Y2 Solution

• 11.11.1 Y2 Solution Company Information
• 11.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Offered
• 11.11.3 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
• 11.11.4 Y2 Solution Main Business Overview
• 11.11.5 Y2 Solution Latest Developments

12 Research Findings and Conclusion

According to this latest study, the 2021 growth of Dry Age-Related Macular Degeneration will have significant change from previous year. By the most conservative estimates of global Dry Age-Related Macular Degeneration market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Dry Age-Related Macular Degeneration market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Age-Related Macular Degeneration market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Oral
Injectables

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Above 40 Years
Above 60 Years
Above 75 Years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research
Y2 Solution
Stealth Biotherapeutics